Lijie Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lijie Zhang has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Jiahao Hao
Department of Laboratory Medicine, Hebei Medical University Third Hospital
11 shared publicationsJiaqing Ye
Department of Laboratory Medicine, Hebei Medical University Third Hospital
11 shared publicationsMinghui Song
Department of Laboratory Medicine, Hebei Medical University Third Hospital
11 shared publicationsWeili Gao
Hebei Key Laboratory of Intractable Pathogens, Shijiazhuang Center for Disease Control and Prevention
10 shared publicationsCuiying Zheng
Department of Laboratory Medicine, Hebei Medical University Third Hospital
9 shared publicationsHuifen Zuo
Department of Laboratory Medicine, Hebei Yiling Hospital
9 shared publications
Latest Publications
- Open Access
- 23 March 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1762789
Mycobacterium fortuitum infection of the hip joint: a case report and literature review
Osteoarticular infections caused by Mycobacterium fortuitum are exceedingly rare and often result in delayed diagnosis due to nonspecific clinical manifestations. We report a case of septic arthritis of the hip in a 47-year-old man, in which M. fortuitum was identified from synovial fluid by 16S rRNA gene sequencing (99% identity to GenBank reference sequence CP011269.1). Upon definitive diagnosis, antimicrobial therapy was adjusted to intravenous azithromycin and levofloxacin combined with oral trimethoprim-sulfamethoxazole (TMP-SMX). Following clinical improvement, treatment was transitioned to oral azithromycin, levofloxacin, and TMP-SMX for 12 months. At the 18-month follow-up, the patient remained in complete remission without recurrence. This case highlights the critical role of 16S rRNA sequencing in diagnosing non-tuberculous mycobacterial infections and informs therapeutic strategies for similar rare infections.
- 23 March 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1762789
Open AccessMycobacterium fortuitum infection of the hip joint: a case report and literature review
Osteoarticular infections caused by Mycobacterium fortuitum are exceedingly rare and often result in delayed diagnosis due to nonspecific clinical manifestations. We report a case of septic arthritis of the hip in a 47-year-old man, in which M. fortuitum was identified from synovial fluid by 16S rRNA gene sequencing (99% identity to GenBank reference sequence CP011269.1). Upon definitive diagnosis, antimicrobial therapy was adjusted to intravenous azithromycin and levofloxacin combined with oral trimethoprim-sulfamethoxazole (TMP-SMX). Following clinical improvement, treatment was transitioned to oral azithromycin, levofloxacin, and TMP-SMX for 12 months. At the 18-month follow-up, the patient remained in complete remission without recurrence. This case highlights the critical role of 16S rRNA sequencing in diagnosing non-tuberculous mycobacterial infections and informs therapeutic strategies for similar rare infections.
- Open Access
- 14 January 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (1) , e0071725
The Brief Case: Knee joint infection caused by Neisseria mucosa
- 14 January 2026
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (1) , e0071725
Open AccessThe Brief Case: Knee joint infection caused by Neisseria mucosa
- 9 September 2025
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 31 (12) , 2105
Corrigendum to “Rice bodies in Brucellar tenosynovitis: a case report” [Clin Microbiol Infect (2025)]
- 9 September 2025
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 31 (12) , 2105
Corrigendum to “Rice bodies in Brucellar tenosynovitis: a case report” [Clin Microbiol Infect (2025)]
- Open Access
- 1 September 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1636778
Case Report: Coxiella burnetii vertebral osteomyelitis in a pigeon breeder: mNGS diagnosis of chronic Q fever
Background: Isolated vertebral osteomyelitis represents an uncommon manifestation of chronic Q fever, posing significant diagnostic challenges. We report a case of Coxiella burnetii-induced spondylodiscitis confirmed via metagenomic next-generation sequencing (mNGS).Case report: A 52-year-old male with occupational avian exposure (pigeon breeder) presented with chronic low back pain persisting for over 1 year, refractory to serial epidural corticosteroid injections. Lumbar MRI demonstrated multifocal osteomyelitis (L3–L5) with associated intraspinal abscess. mNGS analysis of aspirate identified C. burnetii. Targeted dual antimicrobial therapy (vancomycin/doxycycline) induced progressive clinical resolution.Conclusion: Coxiella burnetii, the etiological agent of Q fever, exhibits global distribution and poses significant diagnostic challenges. Its clinical manifestations are frequently nonspecific, typically afebrile, and diagnosis is commonly delayed by months to years post-symptom onset. mNGS offers critical diagnostic utility for early identification and therapeutic intervention in rare spinal infections, thereby mitigating complication risks.
- 1 September 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1636778
Open AccessCase Report: Coxiella burnetii vertebral osteomyelitis in a pigeon breeder: mNGS diagnosis of chronic Q fever
Background: Isolated vertebral osteomyelitis represents an uncommon manifestation of chronic Q fever, posing significant diagnostic challenges. We report a case of Coxiella burnetii-induced spondylodiscitis confirmed via metagenomic next-generation sequencing (mNGS).Case report: A 52-year-old male with occupational avian exposure (pigeon breeder) presented with chronic low back pain persisting for over 1 year, refractory to serial epidural corticosteroid injections. Lumbar MRI demonstrated multifocal osteomyelitis (L3–L5) with associated intraspinal abscess. mNGS analysis of aspirate identified C. burnetii. Targeted dual antimicrobial therapy (vancomycin/doxycycline) induced progressive clinical resolution.Conclusion: Coxiella burnetii, the etiological agent of Q fever, exhibits global distribution and poses significant diagnostic challenges. Its clinical manifestations are frequently nonspecific, typically afebrile, and diagnosis is commonly delayed by months to years post-symptom onset. mNGS offers critical diagnostic utility for early identification and therapeutic intervention in rare spinal infections, thereby mitigating complication risks.
- Open Access
- 13 August 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1618830
Case Report: Mycobacterium abscessus knee joint infection following herbal steam bath: successful short-course oral therapy in an immunocompetent patient
Background: The Mycobacterium abscessus complex (MABC), a multidrug-resistant environmental mycobacterium, rarely causes joint infections, which typically involve prosthetic joints. We describe the first case of native-knee M. abscessus infection linked to herbal steam therapy and osteoarthritis—a previously unreported scenario, accompanied by a literature review of 20 global MABC joint infection cases (2013–2024). Our findings present an alternative approach to the therapeutic guidelines for nontuberculous mycobacteria (NTM) infections, demonstrating successful clinical resolution in this single case using a short-course oral regimen.Case Report: A 54-year-old immunocompetent male with chronic knee osteoarthritis and a 6-year history of knee pain developed acute septic arthritis after knee-level high-temperature herbal steam baths. M. abscessus subsp. abscessus was identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and hsp65 gene sequencing. Despite premature discontinuation of therapy, a 3-month oral regimen of clarithromycin (1,000 mg/day) combined with linezolid (600 mg/day) achieved full functional recovery, evidenced by a daily walking capacity of 8,000 steps.Conclusion: Review of 20 MABC joint infection cases from the literature revealed the knee as the most frequently affected site (55%), with the majority of patients (95%) having a history of joint surgery. This case highlights: 1) Herbal steam therapy, degenerative joint disease, and prior interventions as underrecognized risk factors; 2) Rapid molecular diagnostics (MALDI-TOF MS/hsp65) critical for early diagnosis; 3) Short-course oral therapy (clarithromycin/linezolid) as a potential option for localized infection when prolonged therapy is impractical.
- 13 August 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1618830
Open AccessCase Report: Mycobacterium abscessus knee joint infection following herbal steam bath: successful short-course oral therapy in an immunocompetent patient
Background: The Mycobacterium abscessus complex (MABC), a multidrug-resistant environmental mycobacterium, rarely causes joint infections, which typically involve prosthetic joints. We describe the first case of native-knee M. abscessus infection linked to herbal steam therapy and osteoarthritis—a previously unreported scenario, accompanied by a literature review of 20 global MABC joint infection cases (2013–2024). Our findings present an alternative approach to the therapeutic guidelines for nontuberculous mycobacteria (NTM) infections, demonstrating successful clinical resolution in this single case using a short-course oral regimen.Case Report: A 54-year-old immunocompetent male with chronic knee osteoarthritis and a 6-year history of knee pain developed acute septic arthritis after knee-level high-temperature herbal steam baths. M. abscessus subsp. abscessus was identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and hsp65 gene sequencing. Despite premature discontinuation of therapy, a 3-month oral regimen of clarithromycin (1,000 mg/day) combined with linezolid (600 mg/day) achieved full functional recovery, evidenced by a daily walking capacity of 8,000 steps.Conclusion: Review of 20 MABC joint infection cases from the literature revealed the knee as the most frequently affected site (55%), with the majority of patients (95%) having a history of joint surgery. This case highlights: 1) Herbal steam therapy, degenerative joint disease, and prior interventions as underrecognized risk factors; 2) Rapid molecular diagnostics (MALDI-TOF MS/hsp65) critical for early diagnosis; 3) Short-course oral therapy (clarithromycin/linezolid) as a potential option for localized infection when prolonged therapy is impractical.
- Open Access
- 24 July 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-7
Scedosporium boydii pulmonary infection in an immunocompetent patient with COPD confirmed by next-generation metagenomic sequencing and culture: a case report
Scedosporium boydii infections pose diagnostic challenges due to their nonspecific clinical manifestations and slow growth characteristics in conventional cultures. This paper highlights the diagnostic value of molecular technology combined with targeted prolonged culture for rare fungi. Unitl now, only one case was identified using metagenomic next-generation sequencing (mNGS). This case represents the first report of a 20-day delayed culture confirmation of S. boydii guided by mNGS results in a non-immunocompromised chronic obstructive -with history of COPD who was admitted with fever and cough. Despite two weeks of antibacterial treatment, chest computed tomography (CT) showed worsening infection. To clarify the pathogen, mNGS and bacterial culture of bronchoalveolar lavage fluid (BALF) were performed. Subsequent culture and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) confirmed the growth of Scedosporium species. Based on clinical presentation, chest CT findings, mNGS results, pulmonary Scedosporiosis was diagnosed, and an antifungal treatment regimen (200 mg BID orally) was initiated. Subsequent culture confirmed S. boydii growth and antifungal susceptibility results were also obtained. After six weeks of voriconazole treatment, he was discharged from the hospital and continued to take oral medication for three months. He was fully recovered without recurrence after six months of follow-up. The present case suggests that mNGS findings can unveil cryptic pathogens like Scedosporium. Use mNGS results to trigger intentional, extended targeted cultivation– challenging standard incubation times– especially in non-immunocompromised hosts with underlying lung disease. Seamless clinician-laboratory collaboration is paramount for treatment success.
- 24 July 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-7
Open AccessScedosporium boydii pulmonary infection in an immunocompetent patient with COPD confirmed by next-generation metagenomic sequencing and culture: a case report
Scedosporium boydii infections pose diagnostic challenges due to their nonspecific clinical manifestations and slow growth characteristics in conventional cultures. This paper highlights the diagnostic value of molecular technology combined with targeted prolonged culture for rare fungi. Unitl now, only one case was identified using metagenomic next-generation sequencing (mNGS). This case represents the first report of a 20-day delayed culture confirmation of S. boydii guided by mNGS results in a non-immunocompromised chronic obstructive -with history of COPD who was admitted with fever and cough. Despite two weeks of antibacterial treatment, chest computed tomography (CT) showed worsening infection. To clarify the pathogen, mNGS and bacterial culture of bronchoalveolar lavage fluid (BALF) were performed. Subsequent culture and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) confirmed the growth of Scedosporium species. Based on clinical presentation, chest CT findings, mNGS results, pulmonary Scedosporiosis was diagnosed, and an antifungal treatment regimen (200 mg BID orally) was initiated. Subsequent culture confirmed S. boydii growth and antifungal susceptibility results were also obtained. After six weeks of voriconazole treatment, he was discharged from the hospital and continued to take oral medication for three months. He was fully recovered without recurrence after six months of follow-up. The present case suggests that mNGS findings can unveil cryptic pathogens like Scedosporium. Use mNGS results to trigger intentional, extended targeted cultivation– challenging standard incubation times– especially in non-immunocompromised hosts with underlying lung disease. Seamless clinician-laboratory collaboration is paramount for treatment success.
- 21 July 2025
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 32 (1) , 70-71
Rice bodies in Brucellar tenosynovitis
- 21 July 2025
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 32 (1) , 70-71
Rice bodies in Brucellar tenosynovitis
- Open Access
- 26 May 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1599958
Case Report: Pulmonary mixed infection by Nocardia cyriacigeorgica, Stenotrophomonas maltophilia, and human cytomegalovirus in a patient with minimal change nephrotic syndrome
To our knowledge, this is the first reported case of a pulmonary mixed infection involving Nocardia cyriacigeorgica, Stenotrophomonas maltophilia, and human cytomegalovirus (HCMV) in a patient with minimal change nephrotic syndrome (MCNS), which is of great clinical significance. We report the case of an 18-year-old male with a two-month history of MCNS who was admitted due to fever, cough, and bright red hemoptysis. Upon admission, he was treated with piperacillin/tazobactam and moxifloxacin for one week; however, the therapeutic response was suboptimal. Metagenomic Next-Generation Sequencing (mNGS) and microbiological culture of bronchoalveolar lavage fluid identified a pulmonary mixed infection involving N. cyriacigeorgica, S. maltophilia, and HCMV. Following the initiation of combination therapy with linezolid, trimethoprim-sulfamethoxazole, and ganciclovir, the patient’s condition improved markedly, and he was discharged in a stable condition. One-year follow-up revealed complete recovery with no recurrence. This case highlights the critical role of incorporating advanced molecular diagnostic tools such as mNGS into clinical practice and the need to be vigilance about opportunistic infections involving multiple pathogens, especially in patients receiving immunosuppressive therapy.
- 26 May 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1599958
Open AccessCase Report: Pulmonary mixed infection by Nocardia cyriacigeorgica, Stenotrophomonas maltophilia, and human cytomegalovirus in a patient with minimal change nephrotic syndrome
To our knowledge, this is the first reported case of a pulmonary mixed infection involving Nocardia cyriacigeorgica, Stenotrophomonas maltophilia, and human cytomegalovirus (HCMV) in a patient with minimal change nephrotic syndrome (MCNS), which is of great clinical significance. We report the case of an 18-year-old male with a two-month history of MCNS who was admitted due to fever, cough, and bright red hemoptysis. Upon admission, he was treated with piperacillin/tazobactam and moxifloxacin for one week; however, the therapeutic response was suboptimal. Metagenomic Next-Generation Sequencing (mNGS) and microbiological culture of bronchoalveolar lavage fluid identified a pulmonary mixed infection involving N. cyriacigeorgica, S. maltophilia, and HCMV. Following the initiation of combination therapy with linezolid, trimethoprim-sulfamethoxazole, and ganciclovir, the patient’s condition improved markedly, and he was discharged in a stable condition. One-year follow-up revealed complete recovery with no recurrence. This case highlights the critical role of incorporating advanced molecular diagnostic tools such as mNGS into clinical practice and the need to be vigilance about opportunistic infections involving multiple pathogens, especially in patients receiving immunosuppressive therapy.
- 30 January 2025
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 31 (5) , 783-784
Foot infection of Mycobacterium smegmatis
- 30 January 2025
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 31 (5) , 783-784
Foot infection of Mycobacterium smegmatis
- Open Access
- 2 October 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1423895
Myasthenia gravis complicated with pulmonary infection by Nocardia cyriacigeorgica: a case report and literature review
Myasthenia gravis (MG) is an autoimmune disease. Patients with MG due to compromised autoimmune regulation, progressive muscle weakness, and prolonged use of immunosuppressants and glucocorticoid, often present with concomitant infections. However, cases of MG complicated by Nocardia infection are rare. In this case, we report MG complicated with pulmonary infection by Nocardia cyriacigeorgica. A 71-year-old male farmer who was admitted for management of MG. After 7 weeks of treatment of MG, the patient reported improvement. However, clinical presentation, inflammatory markers, and imaging findings supported a diagnosis of pulmonary infection. To further elucidate the etiology, Nocardia was identified in sputum smear microscopy and sputum culture, with 16S rRNA gene sequencing confirming N. cyriacigeorgica. The patient was prescribed trimethoprim-sulfamethoxazole. After 1 month of treatment, clinical symptoms of MG and pulmonary nocardiosis showed significant improvement. Additionally, we searched PubMed for case reports of Nocardia cyriacigeorgica pulmonary infection from 2010 to 2024 and conducted a statistical analysis of the case information. This report aims to highlights the increased risk of pulmonary Nocardia infection in MG patients after the use of steroids and immunosuppressants, thereby enhancing clinical awareness.
- 2 October 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1423895
Open AccessMyasthenia gravis complicated with pulmonary infection by Nocardia cyriacigeorgica: a case report and literature review
Myasthenia gravis (MG) is an autoimmune disease. Patients with MG due to compromised autoimmune regulation, progressive muscle weakness, and prolonged use of immunosuppressants and glucocorticoid, often present with concomitant infections. However, cases of MG complicated by Nocardia infection are rare. In this case, we report MG complicated with pulmonary infection by Nocardia cyriacigeorgica. A 71-year-old male farmer who was admitted for management of MG. After 7 weeks of treatment of MG, the patient reported improvement. However, clinical presentation, inflammatory markers, and imaging findings supported a diagnosis of pulmonary infection. To further elucidate the etiology, Nocardia was identified in sputum smear microscopy and sputum culture, with 16S rRNA gene sequencing confirming N. cyriacigeorgica. The patient was prescribed trimethoprim-sulfamethoxazole. After 1 month of treatment, clinical symptoms of MG and pulmonary nocardiosis showed significant improvement. Additionally, we searched PubMed for case reports of Nocardia cyriacigeorgica pulmonary infection from 2010 to 2024 and conducted a statistical analysis of the case information. This report aims to highlights the increased risk of pulmonary Nocardia infection in MG patients after the use of steroids and immunosuppressants, thereby enhancing clinical awareness.